PreveCeutical Medical Inc (PRVCF)
0.0186
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
PreveCeutical Medical Net Income (Quarterly): -0.1786M for Sept. 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -0.1786M |
December 31, 2022 | 0.2458M |
September 30, 2022 | -0.6108M |
June 30, 2022 | -0.326M |
March 31, 2022 | -0.4743M |
December 31, 2021 | -0.3722M |
September 30, 2021 | 0.0017M |
June 30, 2021 | -0.6218M |
March 31, 2021 | -0.3913M |
December 31, 2020 | -1.261M |
September 30, 2020 | 0.3382M |
June 30, 2020 | -1.506M |
March 31, 2020 | -0.3884M |
December 31, 2019 | -0.0579M |
September 30, 2019 | -0.4623M |
June 30, 2019 | -1.281M |
Date | Value |
---|---|
March 31, 2019 | -0.8856M |
December 31, 2018 | -4.324M |
September 30, 2018 | -2.00M |
June 30, 2018 | -1.678M |
March 31, 2018 | -1.122M |
December 31, 2017 | -2.119M |
September 30, 2017 | -0.8692M |
June 30, 2017 | -2.290M |
April 30, 2017 | -0.0711M |
January 31, 2017 | -0.0896M |
October 31, 2016 | -0.0809M |
July 31, 2016 | -0.0206M |
April 30, 2016 | -0.0243M |
January 31, 2016 | -0.0124M |
October 31, 2015 | -0.0013M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-1.506M
Minimum
Jun 2020
0.3382M
Maximum
Sep 2020
-0.4591M
Average
-0.3898M
Median
Net Income (Quarterly) Benchmarks
Rimrock Gold Corp | -0.0749M |
InMed Pharmaceuticals Inc | -1.723M |
Venus Concept Inc | -9.794M |
Juva Life Inc | -1.466M |
Lucy Scientific Discovery Inc | -2.620M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 0.1141M |
EPS Diluted (Quarterly) | -0.0003 |
Enterprise Value | 12.73M |
Earnings Yield | -13.38% |
Normalized Earnings Yield | -113.22 |